Prostate Cancer - Results from #1380

Addressing controversial areas in the management of advanced prostate cancer in Canada: Areas of consensus and controversy from the third Canadian consensus forum. February 23, 2024

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study. February 23, 2024

Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. February 23, 2024

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. February 23, 2024

Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials. February 23, 2024

Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy. February 22, 2024

Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs. February 22, 2024

Stereotactic ablative radiation therapy in metastatic prostate cancer. February 22, 2024

Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort. February 22, 2024

Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer. February 22, 2024

Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection. February 22, 2024

Oncologic Outcomes of Testosterone Therapy for Men on Active Surveillance for Prostate Cancer: A Population-based Analysis. February 21, 2024

Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging. February 21, 2024

Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection. February 21, 2024

Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer. February 21, 2024

Treatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study. February 21, 2024

Variability in prostate cancer detection among radiologists and urologists using MRI fusion biopsy. February 20, 2024

Evaluation of Proclarix in the diagnostic work-up of prostate cancer. February 20, 2024

Low PSA radiographic disease progression on C11-choline PET. February 20, 2024

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition. February 20, 2024

Page 70 of 1439